Table 2 Univariate and multivariate Cox regression analysis of overall survival in metastatic prostate cancer patients.
Characteristics | Univariate Cox analysis | Multivariate Cox analysis | ||||
|---|---|---|---|---|---|---|
HR | 95% CI | P value | HR | 95% CI | P value | |
Age at TURP | 1.008 | 0.978–1.040 | 0.601 | 0.961 | 0.929–0.994 | 0.021 |
cT stage at TURP | ||||||
 T2 | Ref. |  |  | Ref. |  |  |
 Otherwise | 4.853 | 2.365–9.960 | <0.001 | 2.981 | 1.381–6.435 | 0.005 |
cN stage at TURP | ||||||
 N0 | Ref. |  |  | Ref. |  |  |
 Otherwise | 2.326 | 1.199–4.512 | 0.013 | 1.215 | 0.538–2.747 | 0.639 |
Gleason Score | 1.687 | 1.240–2.295 | 0.001 | 1.416 | 1.006–1.991 | 0.046 |
PSA at TURP | 0.998 | 0.997–1.000 | 0.081 | 0.999 | 0.998–1.000 | 0.231 |
mPCa subtype | ||||||
 mHSPC | Ref. |  |  | Ref. |  |  |
 mCRPC | 6.870 | 3.872–12.190 | <0.001 | 5.222 | 2.711–10.058 | <0.001 |
ADT prior to TURP |  |  |  | — | — | — |
 No | Ref. |  |  |  |  |  |
 Yes | 24.518 | 0.616–975.953 | 0.089 |  |  |  |
Chemotherapy | ||||||
 No | Ref. |  |  | Ref. |  |  |
 Yes | 2.506 | 1.468–4.277 | 0.001 | 1.688 | 0.933–3.055 | 0.084 |
Radiotherapy | ||||||
 No | Ref. |  |  | Ref. |  |  |
 Yes | 0.763 | 0.181–3.218 | 0.712 | 0.157 | 0.030–0.831 | 0.029 |
TIM3 expression | ||||||
 Positive | Ref. |  |  | Ref. |  |  |
 Negative | 2.865 | 1.224–6.711 | 0.015 | 2.976 | 1.182–7.519 | 0.021 |